In its second wind as a company, Esperion Therapeutics (once owned by Pfizer) has just collected $33 million to continue with clinical trials of its cholesterol-lowering drug.Plymouth, Michigan-based Esperion is ...
Read more
NxThera Inc., a Shoreview, Minnesota-based startup developing a thermal vapor prostate treatment, is bringing in millions of extra investment dollars, including from a corporate partner. ...
Read more
November 5, 2010 10:42 am by Thomas Lee | 0 Comments
NxThera Inc. has raised $2 million from the sale of equity and warrants, according to documents filed with the Securities and Exchange Commission. The startup based in St. Paul is ...
Read more
NxThera Inc. has raised $1 million from the sale of equity and debt, according to documents filed with the Securities and Exchange Commission.The start-up, based in St. Paul, is developing ...
Read more
Delphinus Medical Technologies Inc. has received $8 million in funding commitments to further develop an ultrasonic breast cancer detection device that could become an alternative to mammograms.The funding means that ...
Read more
Obstetricians, nurse-midwives and labor and delivery nurses now have a powerful — and inexpensive — tool for assessing a woman’s risk of delivering a baby too early. CerviLenz.The disposable device ...
Read more
Dr. Brian Duncan caught the business bug as the only clinician on a team of Cleveland Clinic researchers who set out in 2004 to develop a heart-assist pump for infants ...
Read more
February 17, 2010 4:45 pm by Brandon Glenn | 0 Comments
Esperion Therapeutics Inc., a spin-off from Pfizer Inc., has raised an additional $5 million to develop drugs that treat cardiovascular and metabolic disease, according to a SEC filing. The regulatory ...
Read more
January 15, 2010 2:20 pm by Brandon Glenn | 1 Comments
Aastrom, which is developing therapies that use stem cells to treat cardiovascular diseases, priced its shares at 26 cents per unit and hopes to raise $10.9 million from the offering. ...
Read more
January 8, 2010 11:38 am by Brandon Glenn | 1 Comments
Early stage health investor Arboretum Ventures has added George Dunbar, former chief executive of Michigan biotech company Aastrom Biosciences Inc., as a partner. ...
Read more
July 13, 2009 12:23 pm by Chris Seper | 0 Comments
The company said it needed to raise the money to keep up with demand. Accuri launched its Accuri C6 Flow Cytometer in April 2008 and followed that launch three months ...
Read more
The company is developing a disposable device that measures the length of a woman's cervix to help predict risks of preterm birth. It is potentially easier, less costly and just ...
Read more
February 5, 2009 2:13 pm by Mary Vanac | 0 Comments
Biomedical companies with compelling technologies could win millions of dollars in investments this year despite the worst gloom in financial markets since the Great Depression. ...
Read more
